Physician profile
Jonathon Srour
NPI 1386178705
$19,168.08
in general payments reported to CMS, 2019-2025
25 companies · $2,630 in 2025
The $2,630 reported for 2025 was more than what 88% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,762 · 2022: $8,108 · 2023: $3,182 · 2024: $1,486 · 2025: $2,630.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,177 · Food and Beverage: $2,122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,176.69 |
| Food and Beverage | $2,121.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $4,512.13 | 2021-2025 | |
| Vilex LLC | $2,868.63 | 2022 | |
| Paragon 28, INC. | $2,144.96 | 2024-2025 | Monkey Rings, Portfolio |
| Anika Therapeutics, INC. | $2,114.51 | 2022 | |
| Smoky Mountain Surgical LLC | $1,858.74 | 2023-2025 | |
| Medshape, INC. | $1,125.17 | 2021-2022 | |
| Trimed, INC. | $1,065.21 | 2022 | |
| Trilliant Surgical LLC. | $821.68 | 2022-2023 | Arsenal Ankle 10 Hole 1/3 Tubular Plate |
| Stryker Corporation | $720.04 | 2021-2025 | Citrefix, Inbone, Augment Injectable |
| Alpha Orthopedic Systems | $543.99 | 2023 | |
| Organogenesis INC. | $310.18 | 2022-2025 | Via Matrix, Cygnus Dual, Puraply |
| Kerecis Limited | $281.28 | 2021-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Smith+Nephew, INC. | $267.61 | 2021-2025 | Grafix, Stravix, Stravix Pl |
| Orthofix Medical, INC. | $114.93 | 2021-2025 | Physio-Stim |
| Fortis Surgical, LLC | $107.74 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $75.00 | 2021 | |
| Aroa Biosurgery Incorporated | $44.55 | 2023 | |
| Ossur Americas, INC. | $38.47 | 2025 | |
| Biocomposites INC | $35.75 | 2021 | |
| Innovation Technologies INC | $24.72 | 2025 | Irrisept |
| Nevro Corp. | $21.72 | 2023 | Senza |
| Pacira Pharmaceuticals Incorporated | $20.41 | 2025 | Zilretta |
| Vertex Pharmaceuticals Incorporated | $18.89 | 2025 | |
| Music City Medical Technologies, LLC | $18.79 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $12.98 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathon Srour listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.